node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
CD4 | ENSCJAP00000053284 | ENSCJAP00000043597 | ENSCJAP00000053284 | Ig-like domain-containing protein. | Glyceraldehyde-3-phosphate dehydrogenase. | 0.409 |
CD4 | ENSCJAP00000064616 | ENSCJAP00000043597 | ENSCJAP00000064616 | Ig-like domain-containing protein. | Glyceraldehyde-3-phosphate dehydrogenase. | 0.409 |
CD4 | ENSCJAP00000066250 | ENSCJAP00000043597 | ENSCJAP00000066250 | Ig-like domain-containing protein. | Glyceraldehyde-3-phosphate dehydrogenase. | 0.409 |
CD4 | F7EMI9_CALJA | ENSCJAP00000043597 | ENSCJAP00000015309 | Ig-like domain-containing protein. | Glyceraldehyde-3-phosphate dehydrogenase. | 0.409 |
CD4 | F7H580_CALJA | ENSCJAP00000043597 | ENSCJAP00000039153 | Ig-like domain-containing protein. | Glyceraldehyde-3-phosphate dehydrogenase. | 0.409 |
CD4 | IFNG | ENSCJAP00000043597 | ENSCJAP00000056963 | Ig-like domain-containing protein. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons; Belongs to the type II (or gamma) interferon family. | 0.960 |
CD4 | INS | ENSCJAP00000043597 | ENSCJAP00000034117 | Ig-like domain-containing protein. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.691 |
ENSCJAP00000053284 | CD4 | ENSCJAP00000053284 | ENSCJAP00000043597 | Glyceraldehyde-3-phosphate dehydrogenase. | Ig-like domain-containing protein. | 0.409 |
ENSCJAP00000053284 | IFNG | ENSCJAP00000053284 | ENSCJAP00000056963 | Glyceraldehyde-3-phosphate dehydrogenase. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons; Belongs to the type II (or gamma) interferon family. | 0.557 |
ENSCJAP00000053284 | INS | ENSCJAP00000053284 | ENSCJAP00000034117 | Glyceraldehyde-3-phosphate dehydrogenase. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.481 |
ENSCJAP00000064616 | CD4 | ENSCJAP00000064616 | ENSCJAP00000043597 | Glyceraldehyde-3-phosphate dehydrogenase. | Ig-like domain-containing protein. | 0.409 |
ENSCJAP00000064616 | IFNG | ENSCJAP00000064616 | ENSCJAP00000056963 | Glyceraldehyde-3-phosphate dehydrogenase. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons; Belongs to the type II (or gamma) interferon family. | 0.557 |
ENSCJAP00000064616 | INS | ENSCJAP00000064616 | ENSCJAP00000034117 | Glyceraldehyde-3-phosphate dehydrogenase. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.481 |
ENSCJAP00000066250 | CD4 | ENSCJAP00000066250 | ENSCJAP00000043597 | Glyceraldehyde-3-phosphate dehydrogenase. | Ig-like domain-containing protein. | 0.409 |
ENSCJAP00000066250 | IFNG | ENSCJAP00000066250 | ENSCJAP00000056963 | Glyceraldehyde-3-phosphate dehydrogenase. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons; Belongs to the type II (or gamma) interferon family. | 0.557 |
ENSCJAP00000066250 | INS | ENSCJAP00000066250 | ENSCJAP00000034117 | Glyceraldehyde-3-phosphate dehydrogenase. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.481 |
F7EMI9_CALJA | CD4 | ENSCJAP00000015309 | ENSCJAP00000043597 | Glyceraldehyde-3-phosphate dehydrogenase. | Ig-like domain-containing protein. | 0.409 |
F7EMI9_CALJA | GAPDHS | ENSCJAP00000015309 | ENSCJAP00000019030 | Glyceraldehyde-3-phosphate dehydrogenase. | Glyceraldehyde-3-phosphate dehydrogenase. | 0.936 |
F7EMI9_CALJA | IFNG | ENSCJAP00000015309 | ENSCJAP00000056963 | Glyceraldehyde-3-phosphate dehydrogenase. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons; Belongs to the type II (or gamma) interferon family. | 0.557 |
F7EMI9_CALJA | INS | ENSCJAP00000015309 | ENSCJAP00000034117 | Glyceraldehyde-3-phosphate dehydrogenase. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.481 |